244 related articles for article (PubMed ID: 38675155)
1. Preparation and Optimization of MiR-375 Nano-Vector Using Two Novel Chitosan-Coated Nano-Structured Lipid Carriers as Gene Therapy for Hepatocellular Carcinoma.
Soliman B; Wen MM; Kandil E; El-Agamy B; Gamal-Eldeen AM; ElHefnawi M
Pharmaceutics; 2024 Apr; 16(4):. PubMed ID: 38675155
[TBL] [Abstract][Full Text] [Related]
2. Effect of Tumor Suppressor MiR-34a Loaded on ZSM-5 Nanozeolite in Hepatocellular Carcinoma: In Vitro and In Vivo Approach.
Salah Z; Abd El Azeem EM; Youssef HF; Gamal-Eldeen AM; Farrag AR; El-Meliegy E; Soliman B; Elhefnawi M
Curr Gene Ther; 2019; 19(5):342-354. PubMed ID: 31701846
[TBL] [Abstract][Full Text] [Related]
3. Functional Doxorubicin-Loaded Omega-3 Unsaturated Fatty Acids Nanoparticles in Reversing Hepatocellular Carcinoma Multidrug Resistance.
Wang C; Wei X; Shao G
Med Sci Monit; 2021 Feb; 27():e927727. PubMed ID: 33524008
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-200c delivered by solid lipid nanoparticles enhances the effect of paclitaxel on breast cancer stem cell.
Liu J; Meng T; Yuan M; Wen L; Cheng B; Liu N; Huang X; Hong Y; Yuan H; Hu F
Int J Nanomedicine; 2016; 11():6713-6725. PubMed ID: 28003747
[TBL] [Abstract][Full Text] [Related]
5. Chitosan-coated doxorubicin nano-particles drug delivery system inhibits cell growth of liver cancer via p53/PRC1 pathway.
Ye BL; Zheng R; Ruan XJ; Zheng ZH; Cai HJ
Biochem Biophys Res Commun; 2018 Jan; 495(1):414-420. PubMed ID: 29097204
[TBL] [Abstract][Full Text] [Related]
6. Preparation and characterization of dutasteride-loaded nanostructured lipid carriers coated with stearic acid-chitosan oligomer for topical delivery.
Noor NM; Sheikh K; Somavarapu S; Taylor KMG
Eur J Pharm Biopharm; 2017 Aug; 117():372-384. PubMed ID: 28412472
[TBL] [Abstract][Full Text] [Related]
7. Doxorubicin-loaded Fe
Cheng C; Li C; Zhu X; Han W; Li J; Lv Y
J Biomater Appl; 2019 May; 33(10):1373-1381. PubMed ID: 30880566
[TBL] [Abstract][Full Text] [Related]
8. Delivery of miR-375 and doxorubicin hydrochloride by lipid-coated hollow mesoporous silica nanoparticles to overcome multiple drug resistance in hepatocellular carcinoma.
Xue H; Yu Z; Liu Y; Yuan W; Yang T; You J; He X; Lee RJ; Li L; Xu C
Int J Nanomedicine; 2017; 12():5271-5287. PubMed ID: 28769563
[TBL] [Abstract][Full Text] [Related]
9. Ultrasound-Assisted miR-122-Loaded Polymeric Nanodroplets for Hepatocellular Carcinoma Gene Therapy.
Guo H; Xu M; Cao Z; Li W; Chen L; Xie X; Wang W; Liu J
Mol Pharm; 2020 Feb; 17(2):541-553. PubMed ID: 31876426
[TBL] [Abstract][Full Text] [Related]
10.
Sun R; Fang L; Lv X; Fang J; Wang Y; Chen D; Wang L; Chen J; Qi Y; Tang Z; Zhang J; Tian Y
Drug Deliv; 2021 Dec; 28(1):2071-2084. PubMed ID: 34595970
[TBL] [Abstract][Full Text] [Related]
11. MiR-375 delivered by lipid-coated doxorubicin-calcium carbonate nanoparticles overcomes chemoresistance in hepatocellular carcinoma.
Zhao P; Wu S; Cheng Y; You J; Chen Y; Li M; He C; Zhang X; Yang T; Lu Y; Lee RJ; He X; Xiang G
Nanomedicine; 2017 Nov; 13(8):2507-2516. PubMed ID: 28577837
[TBL] [Abstract][Full Text] [Related]
12. Antitumor effect of a new nano-vector with miRNA-135a on malignant glioma.
Liang C; Sun W; He H; Zhang B; Ling C; Wang B; Huang T; Hou B; Guo Y
Int J Nanomedicine; 2018; 13():209-220. PubMed ID: 29343959
[TBL] [Abstract][Full Text] [Related]
13. Combined modality doxorubicin-based chemotherapy and chitosan-mediated p53 gene therapy using double-walled microspheres for treatment of human hepatocellular carcinoma.
Xu Q; Leong J; Chua QY; Chi YT; Chow PK; Pack DW; Wang CH
Biomaterials; 2013 Jul; 34(21):5149-62. PubMed ID: 23578555
[TBL] [Abstract][Full Text] [Related]
14. MiR-375 and Doxorubicin Co-delivered by Liposomes for Combination Therapy of Hepatocellular Carcinoma.
Fan YP; Liao JZ; Lu YQ; Tian DA; Ye F; Zhao PX; Xiang GY; Tang WX; He XX
Mol Ther Nucleic Acids; 2017 Jun; 7():181-189. PubMed ID: 28624193
[TBL] [Abstract][Full Text] [Related]
15. Effects of Cationic Microbubble Carrying CD/TK Double Suicide Gene and αVβ3 Integrin Antibody in Human Hepatocellular Carcinoma HepG2 Cells.
Li J; Zhou P; Li L; Zhang Y; Shao Y; Tang L; Tian S
PLoS One; 2016; 11(7):e0158592. PubMed ID: 27391603
[TBL] [Abstract][Full Text] [Related]
16. Nano polyelectrolyte complexes of carboxymethyl dextran and chitosan to improve chitosan-mediated delivery of miR-145.
Tekie FS; Kiani M; Zakerian A; Pilevarian F; Assali A; Soleimani M; Dinarvand R; Arefian E; Atashi A; Amini M; Atyabi F
Carbohydr Polym; 2017 Mar; 159():66-75. PubMed ID: 28038755
[TBL] [Abstract][Full Text] [Related]
17. MiR-34a overexpression enhances the inhibitory effect of doxorubicin on HepG2 cells.
Zheng SZ; Sun P; Wang JP; Liu Y; Gong W; Liu J
World J Gastroenterol; 2019 Jun; 25(22):2752-2762. PubMed ID: 31235998
[TBL] [Abstract][Full Text] [Related]
18. Chitosan-Coated Solid Lipid Nanoparticles as an Efficient Avenue for Boosted Biological Activities of
Aldayel TS; M Badran M; H Alomrani A; AlFaris NA; Z Altamimi J; S Alqahtani A; A Nasr F; Ghaffar S; Orfali R
Molecules; 2023 Apr; 28(8):. PubMed ID: 37110803
[No Abstract] [Full Text] [Related]
19. Smart co-delivery of plasmid DNA and doxorubicin using MCM-chitosan-PEG polymerization functionalized with MUC-1 aptamer against breast cancer.
Esmaeili Y; Dabiri A; Mashayekhi F; Rahimmanesh I; Bidram E; Karbasi S; Rafienia M; Javanmard SH; Ertas YN; Zarrabi A; Shariati L
Biomed Pharmacother; 2024 Apr; 173():116465. PubMed ID: 38507955
[TBL] [Abstract][Full Text] [Related]
20. Surface modification of nanostructure lipid carrier (NLC) by oleoyl-quaternized-chitosan as a mucoadhesive nanocarrier.
Yostawonkul J; Surassmo S; Iempridee T; Pimtong W; Suktham K; Sajomsang W; Gonil P; Ruktanonchai UR
Colloids Surf B Biointerfaces; 2017 Jan; 149():301-311. PubMed ID: 27780087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
